97 related articles for article (PubMed ID: 20826742)
1. Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients.
Sonnweber T; Theurl I; Seifert M; Schroll A; Eder S; Mayer G; Weiss G
Nephrol Dial Transplant; 2011 Mar; 26(3):977-87. PubMed ID: 20826742
[TBL] [Abstract][Full Text] [Related]
2. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
[TBL] [Abstract][Full Text] [Related]
3. Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis.
Kuragano T; Itoh K; Shimonaka Y; Kida A; Furuta M; Kitamura R; Yahiro M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T
Nephrol Dial Transplant; 2011 Aug; 26(8):2663-7. PubMed ID: 21245128
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin and iron deficiency in pre-kidney transplant patients.
Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
[TBL] [Abstract][Full Text] [Related]
5. Association between circulating electronegative low-density lipoproteins and serum ferritin in hemodialysis patients: a pilot study.
Lobo JC; Farage NE; Abdalla DS; Velarde LG; Torres JP; Mafra D
J Ren Nutr; 2012 May; 22(3):350-6. PubMed ID: 21741859
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
Ferrari P; Mallon D; Trinder D; Olynyk JK
Nephrology (Carlton); 2010 Apr; 15(3):344-9. PubMed ID: 20470305
[TBL] [Abstract][Full Text] [Related]
7. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
8. Safety of intravenous injection of iron saccharate in haemodialysis patients.
Sunder-Plassmann G; Hörl WH
Nephrol Dial Transplant; 1996 Sep; 11(9):1797-802. PubMed ID: 8918625
[TBL] [Abstract][Full Text] [Related]
9. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients.
Costa E; Swinkels DW; Laarakkers CM; Rocha-Pereira P; Rocha S; Reis F; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
Acta Haematol; 2009; 122(4):226-9. PubMed ID: 19887781
[No Abstract] [Full Text] [Related]
11. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang DC; Wang F; Elliott RL; Head JF
Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
[TBL] [Abstract][Full Text] [Related]
12. High levels of tumor necrosis factor-α downregulate antimicrobial iron transport protein, Nramp1, in chronic hemodialysis patients: a key factor for infection risk.
Moriguchi R; Otaki Y; Hazeki S; Shimada T; Matsumoto A; Kakita N; Kaibe S; Kuragano T; Nonoguchi H; Masayoshi N; Hasuike Y; Nakanishi T
Am J Nephrol; 2012; 35(4):372-8. PubMed ID: 22508410
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
Mircescu G; Gârneata L; Capusa C; Ursea N
Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
[TBL] [Abstract][Full Text] [Related]
14. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
Malyszko J; Malyszko JS; Mysliwiec M
Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
[TBL] [Abstract][Full Text] [Related]
15. Involvement of peripheral blood monocytes in haemodialysis: in vivo induction of tumour necrosis factor alpha, interleukin 6 and beta 2-microglobulin.
Pertosa G; Marfella C; Tarantino EA; Di Cillo M; Manno C; Russo R; Schena FP
Nephrol Dial Transplant; 1991; 6 Suppl 2():18-23. PubMed ID: 1866063
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin expression in patients with acute leukaemia.
Cheng PP; Sun ZZ; Jiang F; Tang YT; Jiao XY
Eur J Clin Invest; 2012 May; 42(5):517-25. PubMed ID: 22023453
[TBL] [Abstract][Full Text] [Related]
17. Conventional, but not high-purity, dialysate-induced monocyte apoptosis is mediated by activation of PKC-delta and inflammatory factors release.
Guo LL; Pan Y; Zhu XJ; Tan LY; Xu QJ; Jin HM
Nephrol Dial Transplant; 2011 May; 26(5):1516-22. PubMed ID: 20923925
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
Fishbane S; Lynn RI
Clin Nephrol; 1995 Oct; 44(4):238-40. PubMed ID: 8575123
[TBL] [Abstract][Full Text] [Related]
19. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
[TBL] [Abstract][Full Text] [Related]
20. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
